Skip to main content
Top
Published in: CEN Case Reports 1/2014

01-05-2014 | Case Report

Membranous nephropathy secondary to Graves’ disease with deposits of thyroid peroxidase in an adult

Authors: Koichi Sasaki, Keiko Yasuda, Koichi Nakanishi, Hiromi Rakugi, Yoshitaka Isaka, Masaya Yamato

Published in: CEN Case Reports | Issue 1/2014

Login to get access

Abstract

A 40-year-old woman was diagnosed with Graves’ disease in 2001 and treated with thiamazole, but disease control was poor. She was referred to our hospital in 2011 for exacerbation of proteinuria, which had been present since 2006. Urinalysis showed a protein/creatinine ratio of 4.2 g/gCre and microhematuria, and a renal biopsy was performed. On electron microscopy, high electron density deposits were seen on the epithelial side of the glomerular basement membrane. IgG was also deposited along the glomerular loop wall, and membranous nephropathy was diagnosed. Immunostaining revealed thyroid peroxidase deposits but not thyroglobulin antigen deposits, suggesting that the membranous nephropathy was secondary to Graves’ disease. The membranous nephropathy improved with 131I treatment. To our knowledge, this is the first adult case of membranous nephropathy originating from Graves’ disease in which deposits of thyroid peroxidase antigens have been detected.
Literature
1.
go back to reference Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol. 2005;16:1188–94.PubMedCrossRef Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol. 2005;16:1188–94.PubMedCrossRef
2.
go back to reference Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(Suppl 1):64–71.PubMed Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(Suppl 1):64–71.PubMed
3.
go back to reference Jordan SC, Buckingham B, Sakai R, Olson D. Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med. 1981;304:1212–5.PubMedCrossRef Jordan SC, Buckingham B, Sakai R, Olson D. Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med. 1981;304:1212–5.PubMedCrossRef
4.
go back to reference Horvath F Jr, Teague P, Gaffney EF, Mars DR, Fuller TJ. Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease. Am J Med. 1979;67:901–4.PubMedCrossRef Horvath F Jr, Teague P, Gaffney EF, Mars DR, Fuller TJ. Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease. Am J Med. 1979;67:901–4.PubMedCrossRef
5.
go back to reference Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB. Thyroglobulin-anti-thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol. 1978;9:327–34.PubMedCrossRef Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB. Thyroglobulin-anti-thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol. 1978;9:327–34.PubMedCrossRef
6.
go back to reference Sato Y, Sasaki M, Kan R, Osaku A, Koyama S, Shibayama S, et al. Thyroid antigen-mediated glomerulonephritis in Graves’ disease. Clin Nephrol. 1989;31:49–52.PubMed Sato Y, Sasaki M, Kan R, Osaku A, Koyama S, Shibayama S, et al. Thyroid antigen-mediated glomerulonephritis in Graves’ disease. Clin Nephrol. 1989;31:49–52.PubMed
7.
go back to reference Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, et al. Membranous nephropathy associated with thyroid-peroxidase antigen. Pediatr Nephrol. 2009;24:605–8.PubMedCrossRef Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, et al. Membranous nephropathy associated with thyroid-peroxidase antigen. Pediatr Nephrol. 2009;24:605–8.PubMedCrossRef
8.
go back to reference Becker BA, Fenves AZ, Breslau NA. Membranous glomerulonephritis associated with Graves’ disease. Am J Kidney Dis. 1999;33:369–73.PubMedCrossRef Becker BA, Fenves AZ, Breslau NA. Membranous glomerulonephritis associated with Graves’ disease. Am J Kidney Dis. 1999;33:369–73.PubMedCrossRef
9.
go back to reference O’Regan S, Fong JS, Kaplan BS, Chadarevian JP, Lapointe N, Drummond KN. Thyroid antigen-antibodies nephritis. Clin Immunol Imuunopathol. 1976;6:341–6.CrossRef O’Regan S, Fong JS, Kaplan BS, Chadarevian JP, Lapointe N, Drummond KN. Thyroid antigen-antibodies nephritis. Clin Immunol Imuunopathol. 1976;6:341–6.CrossRef
10.
go back to reference Iwaoka T, Umeda T, Nakayama M, Shimada T, Fujii Y, Miura F, et al. A case of membranous nephropathy associated with thyroid antigens. Jpn J Med. 1982;21:29–34.PubMedCrossRef Iwaoka T, Umeda T, Nakayama M, Shimada T, Fujii Y, Miura F, et al. A case of membranous nephropathy associated with thyroid antigens. Jpn J Med. 1982;21:29–34.PubMedCrossRef
Metadata
Title
Membranous nephropathy secondary to Graves’ disease with deposits of thyroid peroxidase in an adult
Authors
Koichi Sasaki
Keiko Yasuda
Koichi Nakanishi
Hiromi Rakugi
Yoshitaka Isaka
Masaya Yamato
Publication date
01-05-2014
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2014
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-013-0093-y

Other articles of this Issue 1/2014

CEN Case Reports 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.